IP Library › Granted Patent US 11,020,357
Granted Patent B2
US 11,020,357 · App. 16/358,623 · Granted Jun 1, 2021

Compound for use in relief of pain and method to produce thereof

Inventor: Alexandra Yerike (Beverly Hills, CA)
A61K31/05A61K9/0014A61K31/08A61K31/085A61P29/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,020,357
App. No.
16/358,623
Granted
Jun 1, 2021
Kind
B2
Abstract

This present invention provides a composition for use in relief of pain and method of production thereof. The composition comprises cannabidiol (CBD) powder, ethoxydiglycol, essential oils and warming agents. The composition is applied topically to relieve pain, specifically the pain associated with menstrual cramps.

Claims (16)

1. A composition comprising:

a cannabidiol (CBD) powder;

an ethoxydiglycol;

a warming agent;

water; and

a combination of a plurality of natural oils and a plurality of essential oils;

wherein the plurality of natural oils further comprises: a combination of olive oil and coconut oil, and

wherein the plurality of essential oils further comprises 1.25% (weight/weight) of clove bud oil, 1.04% (weight/weight) of lavender oil, 0.87% (weight/weight) of bergamot oil, 0.76% (weight/weight) of geranium oil, 0.625% (weight/weight) of peppermint oil, 0.53% (weight/weight) of turmeric oil, 0.53% (weight/weight) of clary sage oil.

2. The composition of claim 1 , wherein the warming agent is vanillyl butyl ether (VBE).

3. The composition of claim 1 , further comprising moisturizers, preservatives, chelating agents and/or cooling agents.

4. The composition of claim 1 , wherein the cannabidiol (CBD) powder in the range of 0.020% (weight/weight) to 0.030% (weight/weight) of the composition.

5. The composition of claim 4 , wherein the cannabidiol (CBD) powder is in the range of 0.025% (weight/weight) to 0.030% (weight/weight) of the composition.

6. The composition of claim 2 , wherein the vanillyl butyl ether (VBE) is in the range of 0.020% (weight/weight) to 0.028% (weight/weight) of the composition.

7. The composition of claim 1 , wherein the composition is administered topically.

8. The composition of claim 1 , wherein the plurality of natural oils further comprises 3% (weight/weight) of the olive oil and 2.5% (weight/weight) of the coconut oil.

9. The composition of claim 3 , wherein the chelating agent is any one selected from disodium ethylenediaminetetraacetic acid (EDTA), tetrasodium glutamate diacetate and alike chelating agent.

Continuity (2)
Provisional Application 62644854 · Mar 19, 2018
Related Publication 20190282513A1 · Sep 19, 2019